Zelnorm

Sporting Goods: Novartis, Athletes And Doctors

15 Comments

By Ed Silverman // November 12th, 2010 // 9:18 am

Novartis Pays $422M For Off-Label Marketing

9 Comments

By Ed Silverman // September 30th, 2010 // 12:26 pm

Pharmalot… Pharmalittle… The Weekend Nears

1 Comment

By Ed Silverman // July 16th, 2010 // 6:59 am

A Heavy Heart: The FDA Weighs CV Side Effects

1 Comment

By Ed Silverman // November 19th, 2008 // 6:57 am

Novartis To Slash Sales And Marketing

4 Comments

By Ed Silverman // September 16th, 2007 // 11:19 am

Oh, Danny Boy, The Shareholders Are Calling

Make a comment

By Ed Silverman // September 12th, 2007 // 12:10 pm

If Zelnorm Can Return, Why Not Vioxx?

5 Comments

By Ed Silverman // August 5th, 2007 // 10:21 am

The Return Of Zelnorm… Sort Of

6 Comments

By Ed Silverman // July 27th, 2007 // 8:29 am

The FDA: ‘A Cautious Animal?’

3 Comments

By Ed Silverman // March 30th, 2007 // 3:25 pm

Zelnorm: Irritable Heart Syndrome

3 Comments

By Ed Silverman // March 30th, 2007 // 12:26 pm

Clear

Clear

All rights reserved, UBM Canon. Copyright, UBM Canon.

Thanks for trying out the new Pharmalot printing tools. If you're got any suggestions for how we can help you print better, please let us know by clicking on the contact link at http://www.pharmalot.com/